20328 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles
COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM
#902Hypromellose-graft-chitosan and methods thereof for sustained drug delivery
#903Small molecules that promote skin regeneration
#904N-substituted benzamides and methods of use thereof
#905Hepatitis B antiviral agents
#906Topical Pharmaceutical Cosmetic and Disinfectant Compositions Comprising Phosphatidylcholine
#907Anti-fatigue composition
#908Anti-demodectic active agents and topical compositions for the treatment of demodicosis in humans and animals
#909Composition and method for treatment of ulcers
#910Oxymetazoline for the treatment of ano-rectal disorders
#911Selenium-containing compound
#912Platform drug delivery system utilizing crystal engineering and theanine dissolution
#913Platform drug delivery system utilizing crystal engineering and theanine dissolution
#914Platform drug delivery system utilizing crystal engineering and theanine dissolution
#915Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)
#916NOVEL PARASITE THERAPY
#917Prevention and treatment of non-alcoholic fatty liver disease
#918Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them
#919STRONTIUM-CONTAINING COMPLEXES FOR TREATING GASTROESOPHAGEAL REFLUX AND BARRETT'S ESOPHAGUS
#920Combined application of isothiocyanate compound and anti-cancer medicine
#921INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB
#922Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#923Methods for inhibiting muscle atrophy
#9243-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#925Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
#926Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
#927Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting
#928Liver X receptor (LXR) modulators
#929Methods of increasing satellite cell proliferation with kinase inhibitors
#930Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
#931USE OF PHENYLMETHIMAZOLES, METHIMAZOLE DERIVATIVES, AND TAUTOMERIC CYCLIC THIONES FOR THE TREATMENT OF AUTOIMMUNE/INFLAMMATORY DISEASES ASSOCIATED WITH TOLL-LIKE RECEPTOR OVEREXPRESSION
#932GLP-1 receptor modulators
#933Treatment and/or prevention of bone metastasis
#934Combination therapy for neoplasia treatment
#935ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS
#936Medical delivery devices and methods for applying a barrier composition to a targeted skin surface
#937Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#938Treatment of rhinosinusitis with P-glycoprotein inhibitors
#939Compositions and methods for the treatment of presbyopia
#940Compositions and methods for the treatment of presbyopia
#941Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
#942Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
#943PARTIALLY ABSORBABLE FIBER-REINFORCED COMPOSITES FOR CONTROLLED DRUG DELIVERY
#944ROSACEA TREATMENTS AND KITS FOR PERFORMING THEM
#945TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
#946Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
#9471,3-Disubstituted cyclopentane derivatives
#948Dexmedetomidine premix formulation
#949APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM
#950Treatment of papulopustular rosacea with ivermectin
#951Antibiotic Kit and Composition and Uses Thereof
#952Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders
#953Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#954Methods and compositions to prevent or treat bacterial infections
#955METALLO-B-LACTAMASE INHIBITORS
#956Electrified compositions for determining the risk of developing adolescent idiopathic scoliosis through the use of GI protein receptor
#957TREATMENT OF CONDITIONS RELATED TO SHOCK
#958NUTRACEUTICAL COMPOSITION AND METHODS FOR PREVENTING OR TREATING MULTIPLE SCLEROSIS
#959Methods and Compositions for Treating Clostridium difficile Associated Disease
#9601,3-diaminocyclopentane carboxamide derivatives
#961COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#962METHOD OF TREATING AN ANIMAL
#963Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
#964Use of PKC-iota inhibitors for the treatment of breast cancer
#965Ophthalmologic irrigation solutions and method
#966Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability
#967Aqueous-based metronidazole gel formulations
#968Nitric oxide scavengers
#969Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#970Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#971Anti-cancer cycloalkyl diamines
#972Therapeutic compositions comprising imidazole and imidazolium compounds
#973MEDICAMENT AND METHOD OF DIAGNOSIS
#974METHODS OF TREATING PEDIATRIC PATIENTS USING DEXMEDETOMIDINE
#975Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
#976Secnidazole for use in the treatment of bacterial vaginosis
#977Molecular and Herbal Combinations with Methotrexate for Treating Diseases and Inflammatory Ailments
#978Compounds and methods for inducing chondrogenesis
#979Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#980Bruton's tyrosine kinase inhibitor combinations and uses thereof
#981Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
#982RIFAXIMIN FOR USE IN THE TREATING OF VAGINAL INFECTIONS
#983Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
#984Compositions and methods for non-surgical treatment of Ptosis
#985S1P receptors modulators and their use thereof
#986XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY
#987Compounds as opioid receptor modulators
#988Treatment or prevention of hypotension and shock
#989Topical medications for bruises and burns
#990NOVEL THERAPY FOR PROSTATE CARCINOMA
#991Compounds for treatment of cancer
#992Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury
#993Compositions and methods for the treatment of presbyopia
#994METHODS OF USING HISTAMINE RECEPTOR AGONISTS AND ANTAGONISTS
#995IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#996Method for examination of carcinogenic risk
#997Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
#998Methods of Treating Flushing Associated with Carcinoid Tumors and Carcinoid Syndrome
#999Method of treating ovarian cancer using a PKC inhibitor
#1000Composition comprising a TNFR agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma
#1001Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#1002Acylguanidines for treating osteoarthritis
#1003Methods and compositions for treating associated disease
#1004Stabilized oxymetazoline formulations and their uses
#1005USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
#1006Method for the treatment or prevention of lower urinary tract symptoms
#1007Therapeutic compositions comprising imidazole and imidazolium compounds
#1008Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction
#1009Methods for Modulating Sirtuin Enzymes
#1010OIL SUSPENSION OF METRONIDAZOLE
#1011Enteric combination therapy
#1012PHARMACEUTICALLY ACCEPTABLE DOSAGE FORM COMPRISING RELEASE OF MULTIPLE DRUGS FROM SINGLE ORAL DOSAGE FORM
#1013OPHTHALMIC DRUG DELIVERY
#1014Compositions and methods for topical diagnostic and therapeutic transport
#1015Crystal of 5-hydroxy-1H-imidazole-4-carboxamide hydrate and pharmaceutical composition thereof
#1016Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#1017COMBINATION TREATMENT FOR DERMATOLOGICAL CONDITIONS
#1018Synergistic microbicidal combinations
#1019Synergistic microbicidal combinations
#1020Use of TRMP8 for treating opthalmic diseases or conditions involving tearing
#1021Synergistic microbicidal combinations
#1022Synergistic microbicidal combinations
#1023Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#1024Thioredoxin protein inhibitors and uses thereof
#1025Synergistic microbicidal combinations
#1026Selenium-containing compound
#1027Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
#1028NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF
#1029Methods of treating muscular dystrophy
#1030TREATMENT OF SKIN OR MUCOSAL PATHOLOGY
#1031Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye
#1032Storage stable compositions and methods for the treatment of refractive errors of the eye
#1033Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities
#1034METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#1035Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#1036Method for preparing formamidines
#1037Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1038Synergistic microbicidal combinations
#1039Hematopoietic growth factor mimetic small molecule compounds and their uses
#1040Synergistic microbicidal combinations
#1041Therapeutic approaches for treating Parkinson's disease
#1042Microbiota restoration therapy (MRT), compositions and methods of manufacture
#1043Compounds for the treatment of paramoxyvirus viral infections
#1044Medical delivery devices and methods for applying a barrier composition to a targeted skin surface
#1045N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#1046Cyclopropanecarboxylic acid derivative
#1047Synergistic microbicidal combinations
#1048Compounds for the treatment of associated disease
#1049COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE
#1050COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS
#1051METHODS AND COMPOSITIONS FOR INCREASING SOLUBILITY OF AZOLE DRUG COMPOUNDS THAT ARE POORLY SOLUBLE IN WATER
#1052Dual-acting imidazole antihypertensive agents
#1053Topical tetracycline compositions
#10543-O-heteroaryl-ingenol
#1055Synthesis of novel inhibitors of isoprenoid biosynthesis
#1056Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action
#1057Urea compounds and their use as enzyme inhibitors
#1058Substituted quinolines as PDE-10 inhibitors
#1059Veliparib in combination with carboplatin for the treatment of triple negative breast cancer
#1060NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2
#1061Methods of treating hepatic encephalopathy
#1062CANCER TARGETING USING CARBONIC ANHYDRASE ISOFORM IX INHIBITORS
#1063Sodium channel blocker delivery system with scleral lens
#1064COSMETIC AND/OR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION AND RELATED SYNDROMES
#1065Shikimate pathway inhibitors and the use thereof
#1066Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#1067Compositions and methods for lung regeneration
#1068Therapeutic combinations for treating Johne's disease
#1069Methods of colchicine administration
#1070Methods of colchicine administration
#1071Methods of colchicine administration
#1072Formulations for the treatment of vaginal disorders
#1073Treatment of drug resistant cancer
#1074Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function
#1075Dual-acting antihypertensive agents
#1076Compositions and methods for the treatment of presbyopia
#1077Methods of colchicine administration
#1078Tablet containing 5-hydroxy-1H-imidazole-4-carboxamide
#1079Angiogenesis inhibitors
#1080Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
#1081COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION
#1082Microbiota restoration therapy (MRT), compositions and methods of manufacture
#1083Compounds that modulate autoimmunity and methods of using the same
#1084Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#1085Treatment and diagnosis of melanoma
#1086Animal treatments
#1087N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides
#1088Animal treatments
#1089Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
#1090Treatment of papulopustular rosacea with ivermectin
#1091Treatment of papulopustular rosacea with ivermectin
#1092Treatment of inflammatory lesions of rosacea with ivermectin
#1093COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#1094Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders
#1095DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#1096METHODS FOR USING SYNTHETIC TRITERPENOIDS IN THE TREATMENT OF BONE OR CARTILAGE DISEASES OR CONDITIONS
#1097Method for purification of Micafungin
#1098Synergistic combination comprising avermectins and a NSAID for tumor inhibition
#1099Methods for treating gastrointestinal disorders associated with Parkinson's disease, autism, diabetic gastroparesis
#1100COMPOSITIONS FOR THE TREATMENT OF MUCOUS MEMBRANE DISEASES
#1101Compositions and methods for treating extracellular parasitic infections
#1102Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases
#1103Biotherapeutics for the treatment of infectious diseases
#1104TRPV1 antagonists including dihydroxy substituent and uses thereof
#1105Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
#1106Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
#1107METHODS FOR TREATING METHYLMALONIC ACIDEMIA
#1108METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS
#1109Type III secretion inhibitors, analogs and uses thereof
#1110Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#1111CONTROLLED RELEASE COMPOSITIONS
#1112Dual-acting imidazole antihypertensive agents
#1113Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
#1114Methods of increasing satellite cell proliferation
#1115METHODS AND USES OF CYTOCHROME P450 INHIBITORS
#1116Veterinary active agent application
#1117Crystal of 5-hydroxy-1H-imidazole-4-carboxamide 3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1H-imidazole-4-carboxamide hydrate
#1118Methods of inhibiting presbyopia
#1119Compounds and methods for inducing chondrogenesis
#1120Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
#1121Pharmaceutical composition
#1122Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#1123PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION
#1124Tropolone compounds for treating or preventing retroviral infection
#1125Compositions for treatment of skin and ear infections
#1126CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF
#1127Foamable carriers
#1128Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
#1129Ophthalmologic irrigation solutions and method
#1130Pharmaceutical compounds for use in the therapy of infection
#1131Compounds and methods of treating ocular disorders
#1132Methods for lowering blood glucose
#1133COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING MECHANICALLY-INDUCED SKIN INFLAMMATION
#1134Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
#1135Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
#1136Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
#1137Formulation for preventing or reducing bleeding at a surgical site
#1138Method for treating proliferative disorders associated with mutations in c-Met
#1139NDM inhibitor
#1140Ophthalmologic irrigation solutions and method
#1141Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress
#1142Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with disease
#1143Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance
#1144Method for treating and curing leishmaniosis using fexinidazole
#1145Composition and method for treatment of symptoms associated with various skin conditions
#1146HIGH DOSAGE TOPICAL METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS AND THEIR USE TO TREAT ROSACEA
#1147Compounds for use as therapeutic agents affecting p53 expression and/or activity
#1148METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS
#1149SYSTEM AND METHOD FOR DIFFERENTIALLY TIMED LOCAL DELIVERY OF A COMBINATION PHARMACEUTICAL PREPARATION FOR ORAL THERAPY
#1150Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
#1151Conjugates of nitroimidazoles and their use as chemotherapeutic agents
#1152FORMULATIONS OF ENZALUTAMIDE
#1153Compositions for treating CMT and related disorders
#1154Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof
#1155Antagonizing Heparin With Salicylamide Compounds And Histamine Blocking Agents
#1156Dexmedetomidine premix formulation
#1157Biaryl derivatives as nAChR modulators
#1158Skin cream
#1159Pharmaceutical Composition for Treatment of Helicobacter Pylori Associated Diseases
#1160Sodium channel blocker delivery system with scleral lens
#1161Aqueous compositions
#1162RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION
#1163Rosacea treatments using polymetal complexes
#1164MEDICAL PRODUCTS FOR USE IN CONDITIONS RELATED TO MICROBIAL INFECTIONS IN THE UPPER AERODIGESTIVE TRACT
#1165Alpha-1-adrenergic receptor agonist therapy
#1166NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE
#1167PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE AND METHODS OF USE
#1168Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
#1169Pyrazole compounds as CRTH2 antagonists
#1170Benzimidazole-imidazole derivatives
#1171Treatment or prevention of hypotension and shock
#1172Treatment of mild and moderate Alzheimer's disease
#1173Methods for treating dependence
#1174Compositions and methods for tissue engineering and cell based therapies
#1175Use of secnidazole in treatment of dental infections
#1176PHARMACEUTICAL PREPARATIONS CONTAINING HIGHLY VOLATILE SILICONES
#1177Anti-tissue factor antibodies and compositions
#1178Compositions, gels and foams with rheology modulators and uses thereof
#1179Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#1180S1P receptors modulators and their use thereof
#1181Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
#1182Oxymetazoline For The Treatment Of Ano-Rectal Disorders
#1183COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE MUSCLE CONDITIONS
#1184Dapsone to treat rosacea
#1185COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION
#1186Compositions and Methods for Eye Whitening
#1187Compositions for treating neurological disorders
#1188Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#1189Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
#1190Methods for preventing and treating post-traumatic stress disorder (PTSD)
#1191Use of combination preparations comprising antifungal agents
#1192Method for the treatment or prevention of lower urinary tract symptoms
#1193Synthetic triterpenoids and methods of use in the treatment of disease
#1194Fulvene and fulvalene analogs and their use in treating cancers
#1195COMPOSITIONS FOR TREATING ORAL AND PERIODONTAL INFECTIONS
#1196Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
#1197Method of treating ischemia/reperfusion injury
#1198ARYLSULFONAMIDE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF SPECIFIC OPHTHALMOLOGIC DISORDERS
#1199Treatment and prevention of bacterial vaginosis and infections
#1200Compounds for the treatment of -associated disease